News
In the latest twist in the ocean of Zantac-related litigation playing out across state courts, drugmakers have notched a key ...
FDA accepts Milestone's response on Cardamyst nasal spray, sets new PDUFA date; company raises $52.5 million to support ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback